APA (7th ed.) Citation

Holubovska, O., Babich, P., Mironenko, A., Milde, J., Lebed, Y., Stammer, H., . . . Goy, A. (2024, May). RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial. Advances in Respiratory Medicine.

Chicago Style (17th ed.) Citation

Holubovska, Olga, et al. "RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial." Advances in Respiratory Medicine May. 2024.

MLA (9th ed.) Citation

Holubovska, Olga, et al. "RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial." Advances in Respiratory Medicine, May. 2024.